FDA NDC Directory · JSON-LD · Markdown

Oseltamivir Phosphate

NDC 0527-5137 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameoseltamivir phosphate
Labeler / ManufacturerLannett Company, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA213594
Dosage form / routeSUSPENSION · ORAL
Active ingredientsOSELTAMIVIR PHOSPHATE (6 mg/mL)
Marketing started20230713
Package count1

External sources

Source: openFDA. Public-domain (CC0).